ursolic acid has been researched along with mifepristone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cha, HJ; Chung, HY; Kim, KW; Kim, ND; Park, MT; Sato, H; Seiki, M | 1 |
| Aligiannis, N; Kassi, E; Moutsatsou, P; Papoutsi, Z; Pratsinis, H; Sourlingas, TG; Spiliotaki, M | 1 |
2 other study(ies) available for ursolic acid and mifepristone
| Article | Year |
|---|---|
Ursolic acid-induced down-regulation of MMP-9 gene is mediated through the nuclear translocation of glucocorticoid receptor in HT1080 human fibrosarcoma cells.
Topics: Binding Sites; Cell Nucleus; Collagenases; Down-Regulation; Fibrosarcoma; Glucocorticoids; Hormone Antagonists; Humans; Matrix Metalloproteinase 1; Matrix Metalloproteinase 3; Matrix Metalloproteinase 9; Mifepristone; Mitogens; Oligonucleotides; Proto-Oncogene Proteins c-jun; Receptors, Glucocorticoid; RNA, Messenger; Tetradecanoylphorbol Acetate; Transcription Factor AP-1; Triterpenes; Tumor Cells, Cultured; Ursolic Acid | 1998 |
Ursolic acid triggers apoptosis and Bcl-2 downregulation in MCF-7 breast cancer cells.
Topics: Active Transport, Cell Nucleus; Adenocarcinoma; Antineoplastic Agents; Apoptosis; Binding, Competitive; Breast Neoplasms; Cell Line, Tumor; Dexamethasone; Down-Regulation; Drug Screening Assays, Antitumor; Female; Gene Expression Regulation, Neoplastic; Genes, bcl-2; HeLa Cells; Humans; Mifepristone; Neoplasm Proteins; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Receptors, Glucocorticoid; Transcription Factor AP-1; Transcription, Genetic; Triamcinolone; Triterpenes; Ursolic Acid | 2009 |